Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 524

Results For "IND"

6535 News Found

Amity awards Dr Azad Moopen Doctorate for Philanthropy
Sustainability | March 11, 2022

Amity awards Dr Azad Moopen Doctorate for Philanthropy

Over the last 35 years, Dr. Moopen – Founder Chairman and Managing Director of Aster DM Healthcare has played a phenomenal role in strengthening the healthcare delivery system in GCC


Cancer surgeons gather in Delhi to learn new cancer therapies
Public Health | March 11, 2022

Cancer surgeons gather in Delhi to learn new cancer therapies

Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Strides receives USFDA approval for Colchicine tablets
Drug Approval | March 11, 2022

Strides receives USFDA approval for Colchicine tablets

Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout


Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards
Clinical Trials | March 10, 2022

Metropolis Healthcare announces 2nd edition of Healthcare Heroes awards

As a part of its CSR initiatives, the ‘Healthcare Heroes of India’ Awards by Metropolis aims to identify and recognize those individuals and institutions in healthcare sector with a strong sense of purpose and commitment towards patient care and who have prioritized it over all other growth parameters


Medical devices production under PLI scheme gets off the ground
News | March 10, 2022

Medical devices production under PLI scheme gets off the ground

A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore


Gufic Biosciences collaborates with Selvax for cancer treatment
Biotech | March 10, 2022

Gufic Biosciences collaborates with Selvax for cancer treatment

Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours


Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics
News | March 10, 2022

Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics

The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months


Non-hazardous viral inactivation medium for Covid-19 available in Europe
Medical Device | March 10, 2022

Non-hazardous viral inactivation medium for Covid-19 available in Europe

Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing


Gujarat Biotech policy offers incentives to attract small and large firms
News | March 10, 2022

Gujarat Biotech policy offers incentives to attract small and large firms

The Gujarat Biotechnology policy released last month has made radical changes to position the state as a biotechnology hub. It already has a thriving ecosystem of pharma companies and varied suppliers